Table 2.
Clinical parameters: ADL, MMSE, and GDS measured in the ELF-EMF and non-ELF-EMF groups. Data presented as the delta of a clinimetric scale before and after the standard series of treatments (ΔADL = the increase of ADL; ΔMMSE = the increase of MMSE; and ΔGDS = the decrease of GDS).
| Non-ELF-EMF group | ELF-EMF group | p | ||
|---|---|---|---|---|
| ADL | Before treatment | 8.99 | 9.95 | 0.378 |
| After treatment | 14.3 | 16.12 | 0.429 | |
| Δ | 5.31 | 6.17 | 0.194 | |
| p | <0.001 | <0.001 | ||
|
| ||||
| MMSE | Before treatment | 22.75 | 23.00 | 0.873 |
| After treatment | 23.94 | 26.28 | 0.047 | |
| Δ | 1.19 | 3.28 | 0.036 | |
| p | 0.204 | 0.002 | ||
|
| ||||
| GDS | Before treatment | 11.38 | 13.00 | 0.054 |
| After treatment | 9.13 | 6.72 | 0.049 | |
| Δ | 2.25 | 6.28 | 0.018 | |
| p | 0.009 | 0.001 | ||